FOR IMMEDIATE RELEASE
Media Contact: Hervé Le Calvez, Ph.D.
Phone: 1 858 586 0500
San Diego, CA - Abbiotec, LLC. today announces the initiation of business at its new location at 7955 Dunbrook Rd, San Diego, CA 92126.
“We are very excited to begin our operations in the heart of San Diego’s biotech hub, one of the most important world centers for innovative ideas and products in the areas of basic research, diagnostics, and therapeutics” said founder and CEO, Dr. Hervé Le Calvez. “We look forward to serving our research community by providing it with cutting-edge tools and exceptional service, especially novel antibodies that are targeted to high value disease proteins.”
Abbiotec is a company focused on developing and commercializing next generation antibodies and reagents using advanced and proprietary technologies. Abbiotec’s customers will have access to new tools that will assist them in the further understanding of human biology and disease at the cellular and molecular levels, with the hope of ultimately finding cures for human diseases.
Abbiotec will start by offering a large selection of antibodies that target protein families such as cellular antigens, peptidases, protein kinases, and receptors & channels. Later on, the company plans to increase its selection of available antibodies and related reagents to cell adhesion molecules, transporters, transcription and translation factors.